Sound wave weapon joins fight against tough pancreatic cancer
NCT ID NCT05601323
Summary
This study is testing whether adding a focused ultrasound treatment called Suizenji to standard chemotherapy helps people with advanced pancreatic cancer that cannot be surgically removed. It is for patients whose cancer did not respond well to or who could not tolerate their first chemotherapy. Researchers will compare survival and disease control between those who get the ultrasound plus chemo and those who get chemo alone.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UNRESECTABLE PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aichi Medical University Hospital
Nagakute-shi, Aichi, 480-1195, Japan
-
Kanagawa Cancer Center
Yokohama-shi, Kanagawa, 241-8515, Japan
-
Tohoku University Hospital
Sendai-shi, Miyagi, 980-8574, Japan
-
Tokyo Medical University Hospita
Shinjuku-ku, Tokyo, 160-0023, Japan
-
Toyama University Hospital
Toyama-shi, Toyama, 930-0194, Japan
-
Wakayama Medical University Hospital
Wakayama-shi, Wakayama, 641-8510, Japan
-
Yokohama City University Medical Center
Yokohama-shi, Kanagawa, 232-0024, Japan
Conditions
Explore the condition pages connected to this study.